Neoadjuvant Therapy

"Neoadjuvant Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

Descriptor ID	D020360
MeSH Number(s)	E02.186.450
Concept/Terms	Neoadjuvant Therapy Neoadjuvant Therapy Neoadjuvant Therapies Therapies, Neoadjuvant Therapy, Neoadjuvant Neoadjuvant Treatment Neoadjuvant Treatments Treatment, Neoadjuvant Treatments, Neoadjuvant

Below are MeSH descriptors whose meaning is more general than "Neoadjuvant Therapy".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Combined Modality Therapy [E02.186]
Neoadjuvant Therapy [E02.186.450]

Below are MeSH descriptors whose meaning is related to "Neoadjuvant Therapy".

Below are MeSH descriptors whose meaning is more specific than "Neoadjuvant Therapy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoadjuvant Therapy" by people in this website by year, and whether "Neoadjuvant Therapy" was a major or minor topic of these publications.

Bar chart showing 1 publications over 1 distinct years, with a maximum of 1 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2019	0	1	1

Below are the most recent publications written about "Neoadjuvant Therapy" by people in Profiles.

Braman N, Prasanna P, Whitney J, Singh S, Beig N, Etesami M, Bates DDB, Gallagher K, Bloch BN, Vulchi M, Turk P, Bera K, Abraham J, Sikov WM, Somlo G, Harris LN, Gilmore H, Plecha D, Varadan V, Madabhushi A. Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer. JAMA Netw Open. 2019 04 05; 2(4):e192561.

View in: PubMed
Massari F, Santoni M, di Nunno V, Cheng L, Lopez-Beltran A, Cimadamore A, Gasparrini S, Scarpelli M, Battelli N, Montironi R. Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies. Cancer Treat Rev. 2018 Jul; 68:80-85.

View in: PubMed
Huerter ME, Charles EJ, Downs EA, Hu Y, Lau CL, Isbell JM, McMurry TL, Kozower BD. Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant Therapy. Ann Thorac Surg. 2016 Sep; 102(3):948-954.

View in: PubMed
Gilbert CR, Toth JW, Kaifi JT, Belani CP, Varlotto J, Reed MF. Endobronchial valve placement for spontaneous pneumothorax from stage IIIA non-small cell lung cancer facilitates neoadjuvant therapy. Ann Thorac Surg. 2013 Dec; 96(6):2225-7.

View in: PubMed
Rauh-Hain JA, Nitschmann CC, Worley MJ, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, del Carmen MG, Horowitz NS. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecol Oncol. 2013 Apr; 129(1):63-8.

View in: PubMed
Borson R, Harker G, Reeves J, Beck T, Hager S, Horvath W, Jones M, Tillinghast G, Arrowsmith E, Harrer G, Kudrik FJ, Malamud SC, Bromund J, Zeigler H, Tai DF, Kornberg LJ, Obasaju C, Orlando M, Yardley DA. Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer. Clin Breast Cancer. 2012 Oct; 12(5):322-30.

View in: PubMed
Kounalakis N, Gao D, Gonzalez R, Becker M, Lewis K, Poust J, Pearlman N, Robinson W, McCarter M. A neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes. Immunotherapy. 2012 Jul; 4(7):679-86.

View in: PubMed
Medford-Davis L, Decamp M, Recht A, Flickinger J, Belani CP, Varlotto J. Surgical management of early-stage non-small cell lung carcinoma and the present and future roles of adjuvant therapy: a review for the radiation oncologist. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1048-57.

View in: PubMed
Schorge JO, Bradford LS, del Carmen MG. Primary cytoreductive surgery for advanced ovarian cancer: is it the past, present, or future? Clin Adv Hematol Oncol. 2011 Dec; 9(12):912-8.

View in: PubMed
Al-Mansour Z, Verschraegen C. Locally advanced cervical cancer: what is the standard of care? Curr Opin Oncol. 2010 Sep; 22(5):503-12.

View in: PubMed

People

Bloch, Boris

Explore

Similar Concepts

Top Journals